Crispr Therapeutics AG
CRSP
NASDAQ. Currency in USD
44.06 -2.35 ( -5.06% )
Institutions holding this stock
| Date Reported | Institution | Shares Owned | Last Trade | % of AUM | % of total shares |
|---|---|---|---|---|---|
| 30 Sep 2022 | ARK Investment Management LLC | 8.24M | -1.49M | 3.75% | 10.52% |
| 30 Sep 2022 | Capital Research & Mgmt Co - Division 3 | 5.34M | +678,464 | 0.10% | 6.82% |
| 30 Sep 2022 | Nikko Asset Management Americas Inc | 4.26M | -321,362 | 3.54% | 5.44% |
| 30 Sep 2022 | Sumitomo Mitsui Trust Holdings Inc | 4.26M | -321,362 | 0.23% | 5.44% |
| 30 Sep 2022 | BlackRock Inc | 2.35M | +194,458 | 0.01% | 3.00% |
| 30 Sep 2022 | FMR Inc | 2.15M | +527,422 | 0.01% | 2.74% |
| 30 Sep 2022 | NEA Management Company, LLC | 1.59M | +0 | 5.19% | 2.03% |
| 30 Sep 2022 | State Street Corporation | 1.57M | -1,476 | 0.01% | 2.00% |
| 30 Sep 2022 | Bank of America Corp | 1.47M | +243,970 | 0.01% | 1.88% |
| 30 Sep 2022 | Vanguard Group Inc | 1.44M | +112,269 | 0.00% | 1.83% |
| 30 Sep 2022 | Loomis, Sayles & Company LP | 1.25M | -151,059 | 0.16% | 1.59% |
| 30 Sep 2022 | T. Rowe Price Associates, Inc. | 1.19M | -1.83M | 0.01% | 1.52% |
| 30 Sep 2022 | Bellevue Group AG | 928,305 | +6,300 | 0.87% | 1.19% |
| 30 Sep 2022 | Armistice Capital, LLC | 924,000 | -76,000 | 1.05% | 1.18% |
| 30 Sep 2022 | Credit Suisse First Boston (CSFB) | 840,706 | -82,965 | 0.06% | 1.07% |
| 30 Sep 2022 | Geode Capital Management, LLC | 764,676 | +50,481 | 0.01% | 0.98% |
| 30 Sep 2022 | Goldman Sachs Group Inc | 745,906 | +250,700 | 0.01% | 0.95% |
| 30 Sep 2022 | Dimensional Fund Advisors, Inc. | 649,060 | +209,134 | 0.02% | 0.83% |
| 30 Sep 2022 | Charles Schwab Investment Management Inc | 622,118 | +273,995 | 0.01% | 0.79% |
| 30 Sep 2022 | JPMorgan Chase & Co | 612,890 | -50,170 | 0.01% | 0.78% |
| Total | 41.18M | -1.77M | 52.60% | ||
Funds holding this stock
| Date Reported | Institution | Shares Owned | Last Trade | % of AUM | % of total shares |
|---|---|---|---|---|---|
| 30 Sep 2022 | ARK Disruptive Innovation Full Composite | 5.73M | -1.05M | 4.92% | 7.32% |
| 30 Nov 2022 | ARK Innovation ETF | 5.66M | -118,776 | 4.13% | 7.22% |
| 30 Sep 2022 | Capital Group New Perspective Comp | 3.10M | +939,872 | 0.21% | 3.96% |
| 30 Sep 2022 | American Funds New Perspective A | 3.10M | +939,872 | 0.21% | 3.96% |
| 30 Sep 2022 | Nikko AM ARK Disruptive Innovation A USD | 2.34M | -6,402 | 6.16% | 2.99% |
| 30 Sep 2022 | ARK Genomic Revolution | 1.66M | -190,401 | 4.59% | 2.12% |
| 30 Nov 2022 | ARK Genomic Revolution ETF | 1.61M | -20,682 | 3.87% | 2.05% |
| 31 Oct 2022 | Nikko AM ARK Pstv Chg Innovt P JPY Acc | 1.52M | +0 | 3.88% | 1.94% |
| 30 Nov 2022 | SPDR® S&P Biotech ETF | 1.35M | +46,306 | 0.88% | 1.73% |
| 31 Oct 2022 | Vanguard Extended Market Index Investor | 1.07M | +12,877 | 0.07% | 1.36% |
| 30 Sep 2022 | BB Biotech AG Ord | 888,605 | -13,500 | 2.08% | 1.14% |
| 31 Oct 2022 | Fidelity Growth Compy Commingled Pl 3 | 849,077 | +22,161 | 0.09% | 1.08% |
| 30 Sep 2022 | American Funds Growth Fund of Amer A | 800,865 | -755 | 0.03% | 1.02% |
| 30 Sep 2022 | Capital Group Growth Fnd of Amer Comp | 800,865 | -755 | 0.03% | 1.02% |
| 30 Sep 2022 | American Funds SMALLCAP World A | 746,299 | +61,633 | 0.09% | 0.95% |
| 30 Sep 2022 | Macquarie US Smid-Cap Growth Equity | 737,210 | +737,210 | 2.71% | 0.94% |
| 31 Oct 2022 | CS (Lux) Digital Health Equity SB USD | 650,000 | +0 | 1.53% | 0.83% |
| 31 Oct 2022 | Fidelity® Growth Company | 610,259 | -663 | 0.08% | 0.78% |
| 30 Sep 2022 | T. Rowe Price Mid-Cap Growth | 600,000 | +199,049 | 0.15% | 0.77% |
| 30 Nov 2022 | iShares Biotechnology ETF | 570,881 | -3,198 | 0.35% | 0.73% |
| Total | 41.18M | +1.55M | 43.92% | ||